Sprout Pharmaceuticals has won back control of it’s drug Addyi—the first-ever approved drug for low libido in women.
After a long and complicated launch a few years ago, Sprout is relaunching Addyi for half the cost. That’s still $400/mo before insurance and/or coupons they offer patients.
Addyi was developed as an effective treatment for hypoactive sexual desire disorder (HSDD). It received FDA approval in 2015. It has a few limitations: must be taken every day, takes 12 weeks to get to full effect, and women are advised to avoid alcohol while taking it.
With the relaunch, Sprout is offering online televisits with doctors who will diagnose HSDD and then prescribe the medication to appropriate patients. Or, you can visit your personal OBGYN and ask them about Addyi.
It’s not the perfect medication for every woman with decreased sexual desires. A lot of women need more sleep, a lesser share of household chores, and more emotional support from their loved ones. But for women who know they need something extra to increase their libido, Addyi is an option. And, as women, we know that options are good.
El Camino Women’s Medical Group offers the latest Minimally Invasive Solutions for gynecologic problems. Drs. Amy Teng, Erika Balassiano, and Pooja Gupta, all members of AAGL (American Association of Gynecologic Laparoscopy) are highly trained and experienced in the field of Minimally Invasive Gynecgologic Surgery. Dr. Erika Balassiano is also a graduate of the Minimally Invasive Gynecologic Surgery Fellowship at Stanford University, under the supervision of world-renowned Dr. Camran Nezhat.
Serving Mountain View, Los Altos, Los Altos Hills, Atherton, Palo Alto, Redwood City, Burlingame, Saratoga, Cupertino, Sunnyvale, Los Gatos, Campbell, San Jose, Santa Clara, Silicon Valley, Milpitas, Fremont, South Bay, East Bay, North Bay.